CompletedNCT00888264
Antipsychotic use patterns in people with bipolarity and depression
About this title
Read the official source — NCT00888264Observational studyAges 18–65Belgium
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Aarschot and 44 more locationsSee all locations and recruitment
Study information
Study start dateMay 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 152
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Belgium
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00888264
- Official title
Show the full official title
A 6 Month Observational Multicentric Prospective Study Observing the Use of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder, in the Course of a Major Depressive Episode
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Aarschot · Afsnee · Antwerp
42 more locations
- Asse
- Berchem
- Bertrix
- Bierbeek
- Bouge
- Bruges
- Brussels
- Dave
- Dendermonde
- Erpe Mere
- Geel
- Ghent
- Hasselt
- Ixelles-Elsene
- Kortenberg
- Kortrijk
- Laken
- Lebbeke
- Lede
- Leuven
- Libramont
- Lierneux
- Liège
- Lubbeek
- Malle
- Marchienne-au-Pont
- Mons
- Montignies-sur-Sambre
- Namur
- Ottignies
- Roselaere
- Saint Denijs Westrem
- Saint-Servais
- Sint-Josse-ten-Noode
- Sint-Martens-Latem
- Sint-Niklaas
- Sleidinge
- St-Truiden
- Tienen
- Tournai
- Zottegem
- Zoutleeuw
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
Listed age limits: 18 years to 65 years.
